Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: tommysdad who wrote (1383)	3/17/2000 10:10:00 AM
From: A.J. Mullen	Respond to of 3202

"The problem will only come from unethical companies trying to claim they didn't use INCY's data" I don't think that's much of a problem. First, Incyte's customers live and die by IPR. They test interpretations, but outright lying would be dangerous as well as unethical. All biolabs are required to keep detailed logs. The FDA would get very upset if it transpired they had been fiddled. Access to databanks leave traces, and computers have long memories. Also, if a company can be trusted, then it can't trust it's employees, and that will keep itstraight.